✦ LIBER ✦

Clinical risk factors of PEGylated liposomal doxorubicin induced palmar plantar erythrodysesthesia in recurrent ovarian cancer patients

✍ Scribed by Ko, Emily M.; Lippmann, Quinn; Caron, Whitney P.; Zamboni, William; Gehrig, Paola A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predisposing risk factors for palmar-pla

✍ Janos L. Tanyi; Judith A. Smith; Lafit Ramos; Crystal L. Parker; Mark F. Munsell 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 282 KB

Elevated body mass index does not increa

✍ Mary E. Gordinier; Don S. Dizon; Evelyn L. Fleming; Sherry Weitzen; Joanna Schwa 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Prevention of palmar–plantar erythrodyse

✍ Templeton, Arnoud J.; Ribi, Karin; Surber, Christian; Sun, Hong; Hsu Schmitz, Sh 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 352 KB

Interstitial pneumonitis induced by pegy

✍ Kanako Inaba, Takahide Arimoto, Mari Hoya, Kei Kawana, Shunsuke Nakagawa, Shiro 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 170 KB

Association of pegylated liposomal doxor

✍ Florence Joly; Emmanuel Sevin; Alain Lortholary; Frank Priou; J.F. Paitel; Miche 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 299 KB

Cost-minimisation analysis of pegylated

✍ Ojeda, B; de Sande, L M; Casado, A; Merino, P; Casado, M A 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 89 KB